Visit to Intensive Care of 2050
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
The persistent potential of extracorporeal therapies in liver failure.
Fuhrmann V, Bauer M, Wilmer A Intensive Care Med. 2019; 46(3):528-530.
PMID: 31822935 DOI: 10.1007/s00134-019-05886-6.
References
1.
Schulz A, Krabatsch T, Schmitto J, Hetzer R, Seidel M, Dohmen P
. Preliminary Results From the C-Pulse OPTIONS HF European Multicenter Post-Market Study. Med Sci Monit Basic Res. 2016; 22:14-9.
PMC: 4792223.
DOI: 10.12659/MSMBR.896959.
View
2.
Markstedt K, Mantas A, Tournier I, Martinez Avila H, Hagg D, Gatenholm P
. 3D Bioprinting Human Chondrocytes with Nanocellulose-Alginate Bioink for Cartilage Tissue Engineering Applications. Biomacromolecules. 2015; 16(5):1489-96.
DOI: 10.1021/acs.biomac.5b00188.
View
3.
Ren Z, Xu X, Bao Y, He J, Shi L, Deng J
. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician. 2015; 18(2):131-52.
View
4.
Kidir V, Uz E, Yigit A, Altuntas A, Yigit B, Inal S
. Manganese superoxide dismutase, glutathione peroxidase and catalase gene polymorphisms and clinical outcomes in acute kidney injury. Ren Fail. 2016; 38(3):372-7.
DOI: 10.3109/0886022X.2015.1135468.
View
5.
Barnay-Verdier S, Fattoum L, Borde C, Kaveri S, Gibot S, Marechal V
. Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock. Intensive Care Med. 2011; 37(6):957-62.
DOI: 10.1007/s00134-011-2192-6.
View